A study of Codabakalner for males with fragile X syndrome or autism
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study tests an investigational drug called Codabakalner to see if it helps improve symptoms of Fragile X syndrome or autism spectrum disorder in males. It aims to find out if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Males between 13 and 45 years old (if you're in the main study) or between 18 and 45 (if in the earlier part)
- A confirmed diagnosis of Fragile X syndrome or autism spectrum disorder (ASD)
- A caregiver who can help you during the trial
- Be in good general health with no major medical issues
- No uncontrolled seizures in the last 6 months, no recent suicidal thoughts, and no hearing/vision problems that can't be corrected
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if group cognitive behavioral therapy (CBT) can help teens with Fragile X syndrome or autism spectrum disorder improve social and emotional skills. It looks at how teens with these conditions respond to a structured group program.
This trial tests a new medicine called CTH120 to see if it is safe and helpful for adult men with Fragile X syndrome. You may be able to join if you meet certain health and age requirements.
This trial tests if a medicine called suramin (KZ101) can help with social challenges in boys with autism. It's a 12-week study at one location, and families must be able to visit the site easily.
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
This study tests an investigational tablet (TTYP01) to see if it can help adolescents and children with autism spectrum disorder (ASD). The goal is to find out if the drug improves symptoms and is safe for this age group.
This trial tests an investigational drug to reduce aggressive behavior in men with Fragile X syndrome. It aims to see if the drug can help control disruptive outbursts and improve daily life.
Hear when a new Fragile X Syndrome (FXS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.